Learn About Retroperitoneal Liposarcoma

Who are the top Retroperitoneal Liposarcoma Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Retroperitoneal Liposarcoma Clinical Trials?
A Phase 1B Trial of Preoperative Eribulin and Radiation for Retroperitoneal Liposarcoma

Summary: This phase Ib trials studies the side effects and best dose of eribulin mesylate when given together with radiation therapy in treating patients with retroperitoneal liposarcoma that can be removed by surgery. Drugs used in chemotherapy, such as eribulin mesylate, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping t...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Retroperitoneal Liposarcoma?
Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.
A long-term survivor of advanced retroperitoneal dedifferentiated liposarcoma: a successful multimodal approach with extended resection and chemotherapy.
Tired of the same old research?
Check Latest Advances